Impact of Multi-Drug Sequential Therapy on Survival in Patients with Unresectable Hepatocellular Carcinoma

被引：7
|
作者：
Kudo, Masatoshi [1 ]
机构：
[1] Kindai Univ, Fac Med, Dept Gastroenterol & Hepatol, Osaka, Japan
来源：
LIVER CANCER | 2021年 / 10卷 / 01期
关键词：
Molecular targeted therapy; Sorafenib; Regorafenib; Lenvatinib; Sequential therapy; HEPATIC-FUNCTION; KINKI CRITERIA; LENVATINIB; SORAFENIB; PROGNOSIS;
D O I：
10.1159/000514194
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1 / 9
页数：9
相关论文
共 50 条
  • [1] Impact of β-blockers on survival outcomes in patients with unresectable hepatocellular carcinoma
    Altshuler, Ellery
    Aryan, Mahmoud
    Kallumkal, Govind
    Gao, Hanzhi
    Wilson, Jake
    Ouni, Ahmed
    De Leo, Edward
    Hanayneh, Wissam
    Pan, Kelsey
    [J]. HEPATIC ONCOLOGY, 2022, 9 (02)
  • [2] NIVOLUMAB AS SECOND LINE THERAPY IMPROVES SURVIVAL IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA
    Sanai, Faisal M.
    Odah, Hassan
    Alshammari, Kanan
    Alzanbaqi, Adnan
    Alsubhi, Morooj
    Tamim, Hani
    Alolayan, Ashwaq
    Alshehri, Ahmed
    Alqahtani, Saleh A.
    [J]. HEPATOLOGY, 2023, 78 : S1862 - S1863
  • [3] Options and survival benefits of conversion therapy for unresectable hepatocellular carcinoma
    She, Wong Hoi
    Cheung, Tan To
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (18)
  • [4] THE　ROLE　OF　TARGETING　THERAPY　IN　CYTOREDUCTION　AND　SEQUENTIAL　RESECTION　OF　UNRESECTABLE　HEPATOCELLULAR　CARCINOMA
    汤钊猷
    余业勤
    周信达
    马曾辰
    刘康达
    陆继珍
    林芷英
    曾昭冲
    范桢
    杨秉辉
    谢弘
    [J]. Chinese Journal of Cancer Research, 1994, (01) : 24 - 30
  • [5] Nivolumab as Second-Line Therapy Improves Survival in Patients with Unresectable Hepatocellular Carcinoma
    Sanai, Faisal M.
    Odah, Hassan O.
    Alshammari, Kanan
    Alzanbagi, Adnan
    Alsubhi, Murooj
    Tamim, Hani
    Alolayan, Ashwaq
    Alshehri, Ahmed
    Alqahtani, Saleh A.
    [J]. CANCERS, 2024, 16 (12)
  • [6] Impact of the Interval between Transarterial Chemoembolization Sessions on Survival in Patients with Unresectable Hepatocellular Carcinoma
    Kim, Hyung-Don
    An, Jihyun
    Kim, Jin Hyoung
    Gwon, Dong Il
    Shin, Ji Hoon
    Ko, Gi-Young
    Yoon, Hyun-Ki
    Sung, Kyu-Bo
    Kim, Kang Mo
    Lee, Han Chu
    [J]. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2016, 27 (04) : 504 - 513
  • [7] The Impact of Dose on Overall Survival in Unresectable Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy
    Hammad, A. Y.
    Schmid, R. K.
    Erickson, B. A.
    Gamblin, T. C.
    Robbins, J. R.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E152 - E152
  • [8] Antiretroviral therapy improves survival in patients with HIV and multi-drug resistant tuberculosis
    Padayatchi, N.
    Karim, S. Abdool
    Naidoo, K.
    Grobler, A.
    Gengiah, T.
    Friedland, G.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 : E289 - E289
  • [9] Chemoembolization improves survival in patients with unresectable hepatocellular carcinoma (HCC)
    Llovet, JM
    Real, MI
    Vilana, R
    Planas, R
    Coll, S
    Aponte, JJ
    Ayuso, C
    Sala, M
    Muchart, J
    Sola, R
    Rodes, J
    Bruix, J
    [J]. JOURNAL OF HEPATOLOGY, 2001, 34 : 11 - 11
  • [10] Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma
    Yeo, W.
    Mo, F. K. F.
    Koh, J.
    Chan, A. T. C.
    Leung, T.
    Hui, P.
    Chan, L.
    Tang, A.
    Lee, J. J.
    Mok, T. S. K.
    Lai, P. B. S.
    Johnson, P. J.
    Zee, B.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 (07) : 1083 - 1089
12345